Assessment of Bowel Perfusion Using Indocyanine Green Fluorescence Imaging during Laparoscopic Resection of Colorectal Cancer: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202603814227601

Enrollment

Registered

2026-03-24

Start date

2022-11-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Surgery

Interventions

ICG group

Laparoscopic resection of colorectal cancer

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1-Age>18 years 2-Diagnosed with colonic and rectal carcinoma (stage I,II&III) undergoing laparoscopic resection using NIR camera either right hemicolectomy, transverse colectomy, left hemicolectomy, sigmoidectomy, anterior resection or low anterior resection.

Exclusion criteria

Exclusion criteria: 1. Patients with advanced colon cancer stage 4 (according to AJCC classification). 2. Patients with a history of adverse reaction to ICG or to iodine. 3. Chronic kidney disease. 4. Patients undergoing colorectal surgery without anastomosis (such as abdominoperineal resection, Hartmann’s operation) 5. Pregnancy 6. Presented with intestinal obstruction and mergency surgery .

Design outcomes

Primary

Measure	Time frame
Anastomotic leakage rate within 30 days following surgery.	—

Secondary

Measure	Time frame
Operative time (minutes) Need for change in resection margin after perfusion assessment Postoperative complications Length of hospital stay (days)	—

Countries

Egypt

Contacts

Public ContactHaidi abdelzaher Mohamed Zenelden

Associate professor of surgical oncology

drhaidi2014@yahoo.com+201004649147

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026